Feed RDGL
RD

Vivos Inc.

RDGL · OTC

$0.05 -1.23% (-$0.00)
1M -12.44%
Market Cap $23.9M
P/E Ratio -
Div. Yield -
ROE 154.92%
Piotroski F-Score Weak
3/9
Valuation
0 /100
Expensive
P/B 8.66x
P/S 240.72x
EV/EBITDA N/A
Growth
83 /100
Growing
Book val. growth 0.00%
Rev. growth 23.28%
FCF growth N/A
Profitability
0 /100
Weak
Net margin 3,633.27%
Op. margin 2,852.46%
FCF margin 2,513.73%
Quality
0 /100
Poor
ROE 154.92%
ROA 125.04%
Asset turnover 0.03x
Debt
100 /100
Low
Current ratio 48.85x
Debt/Equity 0.04x
Net debt/EBITDA N/A
Stability
43 /100
Moderate
Rev. volatility 95.46%
EPS volatility 11.59%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about RDGL
Online

Sector

Healthcare

Industry

Medical - Devices

CEO

Michael K. Korenko

Employees

1

Headquarters

Kennewick

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.